Evidence map›Paper›PMID 29848566›Full record

ArticleJournal of clinical microbiology2018

Monitoring Anti-Pythium insidiosum IgG Antibodies and (1→3)-β-d-Glucan in Vascular Pythiosis.

Navaporn Worasilchai, Nitipong Permpalung, Pakawat Chongsathidkiet, Asada Leelahavanichkul, Alberto Leonel Mendoza, Tanapat Palaga, Rangsima Reantragoon, Malcolm Finkelman, Pranee Sutcharitchan, Ariya Chindamporn

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Human vaccines & immunotherapeutics · 2024
    Article
  4. Article
  5. Article
  6. Role of Immunotherapy in Pythium insidiosum Keratitis.The American journal of tropical medicine and hygiene · 2022
    Article
  7. Indian journal of ophthalmology · 2022
    Review
  8. A Review: Antimicrobial Therapy for Human Pythiosis.Antibiotics (Basel, Switzerland) · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Antimicrobial agents and chemotherapy · 2020
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Navaporn Worasilchai *Interdisciplinary Program, Medical Microbiology, Graduate School, Chulalongkorn University, Bangkok, Thailand.
Nitipong Permpalung *Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.ORCID 0000-0002-0749-7342
Pakawat ChongsathidkietDepartment of Pathology, Duke University Medical Center, Durham, North Carolina, USA.ORCID 0000-0001-5363-3061
Asada LeelahavanichkulDivision of Immunology, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Alberto Leonel MendozaMicrobiology and Molecular Genetics, Biomedical Laboratory Diagnostics, Michigan State University, East Lansing, Michigan, USA.
Tanapat PalagaDepartment of Microbiology, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.
Rangsima ReantragoonDivision of Immunology, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Malcolm FinkelmanDepartment of Clinical Development, Associates of Cape Cod, Inc., East Falmouth, Massachusetts, USA.
Pranee SutcharitchanDivision of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Ariya ChindampornDivision of Mycology, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand drariya@gmail.com.
Chulalongkorn University · THDuke Medical Center · USMichigan State University · USThai Red Cross Society · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite aggressive treatment, vascular pythiosis has a mortality rate of 40%. This is due to delays in diagnosis and a lack of effective monitoring tools. To overcome this drawback, serum beta-d-glucan (BG) and

Indexed as

AdultAgedAntibodies, BacterialAntifungal Agentsbeta-GlucansBiomarkersFemaleFollow-Up StudiesHumansImmunoglobulin GMaleMicrobial Sensitivity TestsMiddle AgedProspective StudiesPythiosisPythiumAntibodies, BacterialAntifungal Agentsbeta-GlucansBiomarkersImmunoglobulin G(1→3)-β-d-glucanbiomarkersP. insidiosum-specific antibodypythiosistherapeutic monitoring

Identifiers

PMID29848566
PMCPMC6062813
OpenAlexW2953294868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.